Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease.

Detalhes bibliográficos
Autor(a) principal: Lyra, Andre Castro
Data de Publicação: 2007
Outros Autores: Soares, Milena Botelho Pereira, Silva, Luiz Flavio Maia da, Fortes, Marcos Fraga, Silva, André Goyanna Pinheiro, Mota, Augusto César de Andrade, Oliveira, Sheilla Andrade de, Braga, Eduardo Lorens, Carvalho, Wilson Andrade de, Genser, Bernd, Santos, Ricardo Ribeiro dos, Lyra, Luiz Guilherme Costa
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo: https://www.arca.fiocruz.br/handle/icict/10080
Resumo: Hospital São Rafael. Salvador, BA, Brasil / Universidade Federal da Bahia. Salvador, BA, Brasil
id CRUZ_8cd592a7bc2cb57bf0f66d83eedd58e0
oai_identifier_str oai:www.arca.fiocruz.br:icict/10080
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Lyra, Andre CastroSoares, Milena Botelho PereiraSilva, Luiz Flavio Maia daFortes, Marcos FragaSilva, André Goyanna PinheiroMota, Augusto César de AndradeOliveira, Sheilla Andrade deBraga, Eduardo LorensCarvalho, Wilson Andrade deGenser, BerndSantos, Ricardo Ribeiro dosLyra, Luiz Guilherme Costa2015-04-17T17:50:23Z2015-04-17T17:50:23Z2007LYRA, A. C. et al. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World Journal of Gastroenterology, v. 13, n. 7, p. 1067-1073, 2007.1007-9327https://www.arca.fiocruz.br/handle/icict/10080engBaishideng Publishing Group Co. LimitedFeasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease.info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleHospital São Rafael. Salvador, BA, Brasil / Universidade Federal da Bahia. Salvador, BA, BrasilHospital São Rafael. Salvador, BA, Brasil / Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, BrasilHospital São Rafael. Salvador, BA, BrasilHospital São Rafael. Salvador, BA, BrasilHospital São Rafael. Salvador, BA, BrasilFundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, BrasilFundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, Brasil / Fundação Oswaldo Cruz. Centro de Pesquisas Aggeu Magalhaes. Recife, PE, BrasilHospital São Rafael. Salvador, BA, Brasil / Universidade Federal da Bahia. Salvador, BA, BrasilHospital São Rafael. Salvador, BA, BrasilBGStats Consulting. Graz, AustriaHospital São Rafael. Salvador, BA, Brasil / Fundação Oswaldo Cruz. Centro de Pesquisas Gonçalo Moniz. Salvador, BA, BrasilHospital São Rafael. Salvador, BA, Brasil / Universidade Federal da Bahia. Salvador, BA, BrasilAIM: To evaluate the safety and feasibility of bone marrow cell (BMC) transplantation in patients with chronic liver disease on the waiting list for liver transplantation. METHODS: Ten patients (eight males) with chronic liver disease were enrolled to receive infusion of autologous bone marrow-derived cells. Seven patients were classified as Child-Pugh B and three as Child-Pugh C. Baseline assessment included complete clinical and laboratory evaluation and abdominal MRI. Approximately 50 mL of bone marrow aspirate was prepared by centrifugation in a ficoll-hypaque gradient. At least of 100 millions of mononuclear-enriched BMCs were infused into the hepatic artery using the routine technique for arterial chemoembolization for liver tumors. Patients were followed up for adverse events up to 4 mo. RESULTS: The median age of the patients was 52 years (range 24-70 years). All patients were discharged 48 h after BMC infusion. Two patients complained of mild pain at the bone marrow needle puncture site. No other complications or specific side effects related to the procedure were observed. Bilirubin levels were lower at 1 (2.19 +/- 0.9) and 4 mo (2.10 +/- 1.0) after cell transplantation that baseline levels (2.78 +/- 1.2). Albumin levels 4 mo after BMC infusion (3.73 +/- 0.5) were higher than baseline levels (3.47 +/- 0.5). International normalized ratio (INR) decreased from 1.48 (SD = 0.23) to 1.43 (SD = 0.23) one month after cell transplantation. CONCLUSION: BMC infusion into hepatic artery of patients with advanced chronic liver disease is safe and feasible. In addition, a decrease in mean serum bilirubin and INR levels and an increase in albumin levels are observed. Our data warrant further studies in order to evaluate the effect of BMC transplantation in patients with advanced chronic liver disease.Bone marrowCell transplantationLiver failureStem cellCirrhosisTransplante de Medula Óssea/efeitos adversosTransplante de Medula Óssea/métodosHepatopatias/terapiaAdultoIdosoBilirrubina/sangueDoença CrônicaEstudos de ViabilidadeFemininoHumanosInfusões Intra-ArteriaisHepatopatias/metabolismoMasculinoMeia-IdadeAlbumina Sérica/metabolismoinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82352https://www.arca.fiocruz.br/bitstream/icict/10080/1/license.txtafbdf7d7a9bcf771a1cc7edf5f618413MD51ORIGINALLyra A C Feasibility and safety....pdfLyra A C Feasibility and safety....pdfapplication/pdf721437https://www.arca.fiocruz.br/bitstream/icict/10080/2/Lyra%20A%20C%20Feasibility%20%20and%20safety....pdf75ac96704d2533501891f5209c8b6837MD52TEXTLyra A C Feasibility and safety....pdf.txtLyra A C Feasibility and safety....pdf.txtExtracted texttext/plain29191https://www.arca.fiocruz.br/bitstream/icict/10080/3/Lyra%20A%20C%20Feasibility%20%20and%20safety....pdf.txt9817cbe85e96ad617a21dabab694d6d7MD53icict/100802023-03-15 14:33:22.328oai:www.arca.fiocruz.br:icict/10080Q0VTU8ODTyBOw4NPLUVYQ0xVU0lWQSBERSBESVJFSVRPUyBBVVRPUkFJUwoKQW8gYWNlaXRhciBvcyBURVJNT1MgZSBDT05EScOHw5VFUyBkZXN0YSBDRVNTw4NPLCBvIEFVVE9SIGUvb3UgVElUVUxBUiBkZSBkaXJlaXRvcyBhdXRvcmFpcyBzb2JyZSBhIE9CUkEgZGUgcXVlIHRyYXRhIGVzdGUgZG9jdW1lbnRvOgoKQ0VERSBlIFRSQU5TRkVSRSwgdG90YWwgZSBncmF0dWl0YW1lbnRlLCDDoCBGSU9DUlVaIC0gRlVOREHDh8ODTyBPU1dBTERPIENSVVosIGVtIGNhcsOhdGVyIHBlcm1hbmVudGUsIGlycmV2b2fDoXZlbCBlIE7Dg08gRVhDTFVTSVZPLCAKdG9kb3Mgb3MgZGlyZWl0b3MgcGF0cmltb25pYWlzIE7Dg08gQ09NRVJDSUFJUyBkZSB1dGlsaXphw6fDo28gZGEgT0JSQSBhcnTDrXN0aWNhIGUvb3UgY2llbnTDrWZpY2EgaW5kaWNhZGEgYWNpbWEsIGluY2x1c2l2ZSBvcyBkaXJlaXRvcyAKZGUgdm96IGUgaW1hZ2VtIHZpbmN1bGFkb3Mgw6AgT0JSQSwgZHVyYW50ZSB0b2RvIG8gcHJhem8gZGUgZHVyYcOnw6NvIGRvcyBkaXJlaXRvcyBhdXRvcmFpcywgZW0gcXVhbHF1ZXIgaWRpb21hIGUgZW0gdG9kb3Mgb3MgcGHDrXNlczsKICAgICAgICAKQUNFSVRBIHF1ZSBhIGNlc3PDo28gdG90YWwgbsOjbyBleGNsdXNpdmEsIHBlcm1hbmVudGUgZSBpcnJldm9nw6F2ZWwgZG9zIGRpcmVpdG9zIGF1dG9yYWlzIHBhdHJpbW9uaWFpcyBuw6NvIGNvbWVyY2lhaXMgZGUgdXRpbGl6YcOnw6NvIApkZSBxdWUgdHJhdGEgZXN0ZSBkb2N1bWVudG8gaW5jbHVpLCBleGVtcGxpZmljYXRpdmFtZW50ZSwgb3MgZGlyZWl0b3MgZGUgZGlzcG9uaWJpbGl6YcOnw6NvIGUgY29tdW5pY2HDp8OjbyBww7pibGljYSBkYSBPQlJBLCBlbSBxdWFscXVlciAKbWVpbyBvdSB2ZcOtY3VsbywgaW5jbHVzaXZlIGVtIFJlcG9zaXTDs3Jpb3MgRGlnaXRhaXMsIGJlbSBjb21vIG9zIGRpcmVpdG9zIGRlIHJlcHJvZHXDp8OjbywgZXhpYmnDp8OjbywgZXhlY3XDp8OjbywgZGVjbGFtYcOnw6NvLCBleHBvc2nDp8OjbywgCmFycXVpdmFtZW50bywgaW5jbHVzw6NvIGVtIGJhbmNvIGRlIGRhZG9zLCBwcmVzZXJ2YcOnw6NvLCBkaWZ1c8OjbywgZGlzdHJpYnVpw6fDo28sIGRpdnVsZ2HDp8OjbywgZW1wcsOpc3RpbW8sIHRyYWR1w6fDo28sIGluY2x1c8OjbyBlbSBub3ZhcyAKb2JyYXMgb3UgY29sZXTDom5lYXMsIHJldXRpbGl6YcOnw6NvLCBlZGnDp8OjbywgcHJvZHXDp8OjbyBkZSBtYXRlcmlhbCBkaWTDoXRpY28gZSBjdXJzb3Mgb3UgcXVhbHF1ZXIgZm9ybWEgZGUgdXRpbGl6YcOnw6NvIG7Do28gY29tZXJjaWFsOwogICAgICAgIApSRUNPTkhFQ0UgcXVlIGEgY2Vzc8OjbyBhcXVpIGVzcGVjaWZpY2FkYSBjb25jZWRlIMOgIEZJT0NSVVogLSBGVU5EQcOHw4NPIE9TV0FMRE8gQ1JVWiBvIGRpcmVpdG8gZGUgYXV0b3JpemFyIHF1YWxxdWVyIHBlc3NvYSDigJMgZsOtc2ljYSAKb3UganVyw61kaWNhLCBww7pibGljYSBvdSBwcml2YWRhLCBuYWNpb25hbCBvdSBlc3RyYW5nZWlyYSDigJMgYSBhY2Vzc2FyIGUgdXRpbGl6YXIgYW1wbGFtZW50ZSBhIE9CUkEsIHNlbSBleGNsdXNpdmlkYWRlLCBwYXJhIHF1YWlzcXVlciAKZmluYWxpZGFkZXMgbsOjbyBjb21lcmNpYWlzOwogICAgICAgIApERUNMQVJBIHF1ZSBhIG9icmEgw6kgY3JpYcOnw6NvIG9yaWdpbmFsIGUgcXVlIMOpIG8gdGl0dWxhciBkb3MgZGlyZWl0b3MgYXF1aSBjZWRpZG9zIGUgYXV0b3JpemFkb3MsIHJlc3BvbnNhYmlsaXphbmRvLXNlIGludGVncmFsbWVudGUgCnBlbG8gY29udGXDumRvIGUgb3V0cm9zIGVsZW1lbnRvcyBxdWUgZmF6ZW0gcGFydGUgZGEgT0JSQSwgaW5jbHVzaXZlIG9zIGRpcmVpdG9zIGRlIHZveiBlIGltYWdlbSB2aW5jdWxhZG9zIMOgIE9CUkEsIG9icmlnYW5kby1zZSBhIAppbmRlbml6YXIgdGVyY2Vpcm9zIHBvciBkYW5vcywgYmVtIGNvbW8gaW5kZW5pemFyIGUgcmVzc2FyY2lyIGEgRklPQ1JVWiAtIEZVTkRBw4fDg08gT1NXQUxETyBDUlVaIGRlIGV2ZW50dWFpcyBkZXNwZXNhcyBxdWUgdmllcmVtIGEgCnN1cG9ydGFyLCBlbSByYXrDo28gZGUgcXVhbHF1ZXIgb2ZlbnNhIGEgZGlyZWl0b3MgYXV0b3JhaXMgb3UgZGlyZWl0b3MgZGUgdm96IG91IGltYWdlbSwgcHJpbmNpcGFsbWVudGUgbm8gcXVlIGRpeiByZXNwZWl0byBhIHBsw6FnaW8gCmUgdmlvbGHDp8O1ZXMgZGUgZGlyZWl0b3M7CiAgICAgICAgCkFGSVJNQSBxdWUgY29uaGVjZSBhIFBvbMOtdGljYSBJbnN0aXR1Y2lvbmFsIGRlIEFjZXNzbyBBYmVydG8gZGEgSW5zdGl0dWnDp8OjbyBlIGFzIGRpcmV0cml6ZXMgcGFyYSBvIGZ1bmNpb25hbWVudG8gZG8gcmVwb3NpdMOzcmlvIAppbnN0aXR1Y2lvbmFsIEFSQ0EKRepositório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352023-03-15T17:33:22Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease.
title Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease.
spellingShingle Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease.
Lyra, Andre Castro
Bone marrow
Cell transplantation
Liver failure
Stem cell
Cirrhosis
Transplante de Medula Óssea/efeitos adversos
Transplante de Medula Óssea/métodos
Hepatopatias/terapia
Adulto
Idoso
Bilirrubina/sangue
Doença Crônica
Estudos de Viabilidade
Feminino
Humanos
Infusões Intra-Arteriais
Hepatopatias/metabolismo
Masculino
Meia-Idade
Albumina Sérica/metabolismo
title_short Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease.
title_full Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease.
title_fullStr Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease.
title_full_unstemmed Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease.
title_sort Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease.
author Lyra, Andre Castro
author_facet Lyra, Andre Castro
Soares, Milena Botelho Pereira
Silva, Luiz Flavio Maia da
Fortes, Marcos Fraga
Silva, André Goyanna Pinheiro
Mota, Augusto César de Andrade
Oliveira, Sheilla Andrade de
Braga, Eduardo Lorens
Carvalho, Wilson Andrade de
Genser, Bernd
Santos, Ricardo Ribeiro dos
Lyra, Luiz Guilherme Costa
author_role author
author2 Soares, Milena Botelho Pereira
Silva, Luiz Flavio Maia da
Fortes, Marcos Fraga
Silva, André Goyanna Pinheiro
Mota, Augusto César de Andrade
Oliveira, Sheilla Andrade de
Braga, Eduardo Lorens
Carvalho, Wilson Andrade de
Genser, Bernd
Santos, Ricardo Ribeiro dos
Lyra, Luiz Guilherme Costa
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Lyra, Andre Castro
Soares, Milena Botelho Pereira
Silva, Luiz Flavio Maia da
Fortes, Marcos Fraga
Silva, André Goyanna Pinheiro
Mota, Augusto César de Andrade
Oliveira, Sheilla Andrade de
Braga, Eduardo Lorens
Carvalho, Wilson Andrade de
Genser, Bernd
Santos, Ricardo Ribeiro dos
Lyra, Luiz Guilherme Costa
dc.subject.en.pt_BR.fl_str_mv Bone marrow
Cell transplantation
Liver failure
Stem cell
Cirrhosis
topic Bone marrow
Cell transplantation
Liver failure
Stem cell
Cirrhosis
Transplante de Medula Óssea/efeitos adversos
Transplante de Medula Óssea/métodos
Hepatopatias/terapia
Adulto
Idoso
Bilirrubina/sangue
Doença Crônica
Estudos de Viabilidade
Feminino
Humanos
Infusões Intra-Arteriais
Hepatopatias/metabolismo
Masculino
Meia-Idade
Albumina Sérica/metabolismo
dc.subject.decs.pt_BR.fl_str_mv Transplante de Medula Óssea/efeitos adversos
Transplante de Medula Óssea/métodos
Hepatopatias/terapia
Adulto
Idoso
Bilirrubina/sangue
Doença Crônica
Estudos de Viabilidade
Feminino
Humanos
Infusões Intra-Arteriais
Hepatopatias/metabolismo
Masculino
Meia-Idade
Albumina Sérica/metabolismo
description Hospital São Rafael. Salvador, BA, Brasil / Universidade Federal da Bahia. Salvador, BA, Brasil
publishDate 2007
dc.date.issued.fl_str_mv 2007
dc.date.accessioned.fl_str_mv 2015-04-17T17:50:23Z
dc.date.available.fl_str_mv 2015-04-17T17:50:23Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv LYRA, A. C. et al. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World Journal of Gastroenterology, v. 13, n. 7, p. 1067-1073, 2007.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/10080
dc.identifier.issn.none.fl_str_mv 1007-9327
identifier_str_mv LYRA, A. C. et al. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World Journal of Gastroenterology, v. 13, n. 7, p. 1067-1073, 2007.
1007-9327
url https://www.arca.fiocruz.br/handle/icict/10080
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Baishideng Publishing Group Co. Limited
publisher.none.fl_str_mv Baishideng Publishing Group Co. Limited
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/10080/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/10080/2/Lyra%20A%20C%20Feasibility%20%20and%20safety....pdf
https://www.arca.fiocruz.br/bitstream/icict/10080/3/Lyra%20A%20C%20Feasibility%20%20and%20safety....pdf.txt
bitstream.checksum.fl_str_mv afbdf7d7a9bcf771a1cc7edf5f618413
75ac96704d2533501891f5209c8b6837
9817cbe85e96ad617a21dabab694d6d7
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1798324966272270336